Sometimes, moving our bodies is the LAST thing we want to do. Cancer survivorship can be exhausting. Fatigue is one of the most common effects of cancer treatment. And, the more late effects begin to pile up, the more tired we become, and the more likely we are to succumb to the couch. But there are many, many reasons why we shouldn’t.
Even a small amount of exercise can have a significant impact. Just about everyone can benefit from a daily walk.
Being diagnosed with cancer at any age puts many in a tailspin.
Insomnia is one of the most common late effects of cancer treatment, yet it is often overlooked in survivorship care. Fewer than half of NCI-designated cancer centers routinely screen for sleep problems, and many oncologists and nurses rarely ask about it. As a result, fewer than one in five survivors struggling with sleep ever mention it to their care team. Effective treatments for insomnia do exist, but they are not always discussed due to lack of time, knowledge, or resources.
One night in 1981, in the middle of bath time, Marty Gonzalez noticed a strange glow that seemed to emanate from inside one of the eyes of her 9-month-old daughter, Marissa.
Patients with cancer had a higher rate of acute MI when presenting to the ED with chest pain.
The number of cancer survivors with self-reported functional limitations throughout the United States has more than doubled over the past 2 decades, according to data published in JAMA Oncology.
Childhood cancer survivors have increased rates of undergoing late, major surgical procedures 5 or more years after diagnosis, according to data from the Childhood Cancer Survivor Study.
The first study to demonstrate an association between therapeutic radiation dose to the large bowel and colorectal cancer.
Meet Sheilagh Foley, a Hodgkin’s survivor with a familiar tale to tell, and she does it so beautifully. Hodgkin’s International was mentioned as a resource, and we are thrilled to have the “shout out!”
In a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s, showed signs of being an average of 7.7 years older biologically than their peers and placing them at risk for cognitive problems.